Cystathionine β-synthase expression correlates with tumor development and poor prognosis in patients with adenocarcinoma of the gastroesophageal junction

被引:1
|
作者
Liu, Guang-Jie [1 ]
Hu, Xiao-Jie [2 ]
Huo, Bing-Jie [3 ]
Yue, Meng [4 ]
Liu, Fang [1 ]
Chang, Liang [5 ]
机构
[1] Hebei Med Univ, Dept Thorac Surg, Affiliated Hosp 4, Shijiazhuang 050001, Hebei, Peoples R China
[2] Hebei Prov Peoples Hosp, Dept Gen Surg, Shijiazhuang 050055, Hebei, Peoples R China
[3] Hebei Med Univ, Dept Chinese Med, Affiliated Hosp 4, Shijiazhuang 050001, Hebei, Peoples R China
[4] Hebei Med Univ, Dept Pathol, Affiliated Hosp 4, Shijiazhuang 050001, Hebei, Peoples R China
[5] Hebei Univ Chinese Med, Dept Basic Theories Chinese Med, Shijiazhuang 050200, Hebei, Peoples R China
来源
关键词
Cystathionine beta-synthase; adenocarcinoma of the gastroesophageal junction; immunohistochemistry; ENDOTHELIAL GROWTH-FACTOR; HYDROGEN-SULFIDE; ESOPHAGEAL; CANCER; EPIDEMIOLOGY; CARCINOMA; RISK; ANGIOGENESIS; ATTENUATION; VEGF;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To reveal the expression level of cystathionine beta-synthase (CBS) in adenocarcinoma of esophagogastric junction (AEG) and discuss the relationship between CBS expression level and tumor microvascular density (MVD), clinical features and prognosis. Methods: Paraffin samples from 214 patients with AEG were selected to make pathological microchips. Immunohistochemistry was performed based on the microchips to detect the expression level of CBS and microvascular density (MVD) in cancer tissues and adjacent control tissues. Relationships between expression level of CBS and MVD, clinical characteristics and prognosis were analyzed. Results: In total, 214 AEG cases were classified into three groups: CBS negative staining (n=26), low staining (n=44), and high staining (n=144). Quantitative alterations in CBS and CD31 expression were explored using immunohistochemistry. The 5-year recurrence rate of enrolled patients was followed up and found that CBS expression was significantly increased in tumor tissue compared with adjacent non-tumor tissue (P<0.0001). There were significant differences in microvascular density between the groups with negative and high CBS staining (P<0.0001), and between the groups with low and high CBS staining (P<0.0001). Univariate analysis revealed significant differences in tumor stage (P<0.0001), T stage (P=0.008), N stage (P=0.028), differentiation degree (P=0.037), and 5-year survival (P=0.0034) among the three groups. Multivariate logic regression analysis showed that increased CBS scores were associated with an increased probability of 5-year recurrence (P=0.018). Finally, different CBS expression levels were associated with disease-free survival in AEG patients. Conclusions: CBS expression level is closely related to microvascular density and tumor stage in AEG. High level of CBS not only accelerates tumor angiogenesis but also affects patient's survival and prognosis.
引用
收藏
页码:2739 / 2748
页数:10
相关论文
共 50 条
  • [1] Cystathionine β-synthase expression correlates with tumor development and poor prognosis in lung squamous cell carcinoma patients
    Han, Ya-Qing
    Zhang, Zi-Bo
    Wang, Kun
    Liu, Guang-Jie
    Xie, Shao-Nan
    Liu, Qing-Yi
    Liu, Fang
    NEOPLASMA, 2022, 69 (04) : 868 - 876
  • [2] Keratin 17 Expression Correlates with Tumor Progression and Poor Prognosis in Gastric Adenocarcinoma
    Ide, Munenori
    Kato, Toshihide
    Ogata, Kyoichi
    Mochiki, Erito
    Kuwano, Hiroyuki
    Oyama, Tetsunari
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (11) : 3506 - 3514
  • [3] Keratin 17 Expression Correlates with Tumor Progression and Poor Prognosis in Gastric Adenocarcinoma
    Munenori Ide
    Toshihide Kato
    Kyoichi Ogata
    Erito Mochiki
    Hiroyuki Kuwano
    Tetsunari Oyama
    Annals of Surgical Oncology, 2012, 19 : 3506 - 3514
  • [4] Expression of cystathionine β-synthase is downregulated in hepatocellular carcinoma and associated with poor prognosis
    Kim, Jongmin
    Hong, Seok Joo
    Park, Jun Ho
    Park, Sun Young
    Kim, Seung Whan
    Cho, Eun Yoon
    Do, In-Gu
    Joh, Jae-Won
    Kim, Dae Shick
    ONCOLOGY REPORTS, 2009, 21 (06) : 1449 - 1454
  • [5] Cystathionine-β-synthase expression correlates with tumour progression and adverse prognosis in patients with colon cancer
    Hu, Xiao-Jie
    Sun, Yun
    Liu, Guang-Jie
    Zhang, Juan
    Zhang, Li-Xiao
    Peng, Yan-Hui
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (09)
  • [6] Expression of histone deacetylase 1 correlates with a poor prognosis in patients with adenocarcinoma of the lung
    Minamiya, Yoshihiro
    Ono, Takashi
    Saito, Hajime
    Takahashi, Naoko
    Ito, Manabu
    Mitsui, Masafumi
    Motoyama, Satoru
    Ogawa, Junichi
    LUNG CANCER, 2011, 74 (02) : 300 - 304
  • [7] Cytoplasmic Maspin Expression Correlates with Poor Prognosis of Patients with Adenocarcinoma of the Uterine Cervix
    Nosaka, Kanae
    Horie, Yasushi
    Shiomi, Tatsushi
    Itamochi, Hiroaki
    Oishi, Tetsuro
    Shimada, Muneaki
    Sato, Shinya
    Sakabe, Tomohiko
    Harada, Tasuku
    Umekita, Yoshihisa
    YONAGO ACTA MEDICA, 2015, 58 (04) : 151 - 156
  • [8] Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
    Kato, Shumei
    Okamura, Ryosuke
    Baumgartner, Joel M.
    Patel, Hitendra
    Leichman, Lawrence
    Kelly, Kaitlyn
    Sicklick, Jason K.
    Fanta, Paul T.
    Lippman, Scott M.
    Kurzrock, Razelle
    CLINICAL CANCER RESEARCH, 2018, 24 (24) : 6248 - 6256
  • [9] Reduced Expression of PTPRD Correlates with Poor Prognosis in Gastric Adenocarcinoma
    Wang, Dandan
    Wang, Leilei
    Zhou, Jun
    Pan, Jihong
    Qian, Wei
    Fu, Jiafang
    Zhang, Genglin
    Zhu, Youming
    Liu, Chunshan
    Wang, Chunliang
    Jin, Zongkun
    He, Ziqing
    Wu, Jianmei
    Shi, Bin
    PLOS ONE, 2014, 9 (11):
  • [10] Over-Expression of GGPPs Contributes to Tumor Metastasis and Correlates with Poor Prognosis of Lung Adenocarcinoma
    Lv, T.
    Wang, X.
    Xu, W.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1921 - S1921